Statistics for Dermapharm Holding SE (id:2642 DMP)

Valuation metrics

Market cap

1.83B

Enterprise value

2.75B

Trailing P/E (ttm)

22.08

Forward P/E

14.47

PEG ratio

14.47

Price/Sales (ttm)

1.60

Price/Book (mrq)

3.33

Enterprise Value/Revenue

2.40

Enterprise Value/EBITDA

12.65

Overview

Shares outstanding

53.84M

Float

17.00M

Shares short

% Held by insiders

0.68%

% Held by institutions

0.16%

Average volume (10 days)

30.39K

Average volume (90 days)

Price summary

52-Week low

30.15

52-Week high

43.22

52-Week change

-9.33%

Beta

1.14

50-Day moving average

32.64

200-Day moving average

34.80

Dividends and splits

Forward annual dividend rate

3.52

Forward annual dividend yield

0.10

Trailing annual dividend rate

0.88%

Trailing annual dividend yield

0.03

5-Year annual dividend yield

2.58

Payout ratio

0.57

Dividend date

Ex-dividend date

June 28th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

7.24%

Operating margin

10.03%

Operational effectiveness

Return on assets

5.71%

Return on equity

15.00%

Income statement

Revenue (ttm)

21.25

Revenue per share (ttm)

21.25

Quarterly revenue growth (yoy)

Gross profit (ttm)

719.16M

EBITDA

289.68M

Net income to common (ttm)

83.04M

Diluted EPS (ttm)

1.54

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

165.76M

Total cash per share (mrq)

3.07

Total debt (mrq)

1.08B

Total Debt/Equity (mrq)

193.81

Current ratio (mrq)

158.10%

Book value per share (mrq)

10.22

Cash flow

Cash flow statement

187.31M

Levered free cash flow (LFCF)

155.19M